DCT
1:20-cv-00985
Acadia Pharma Inc v. Aurobindo Pharma Ltd
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (01/11/24)
Patent Owner
Operating Company (W)
PACER
1:20-cv-00985
Nature of Suit835 ANDA
Appeals
CourtD. Delaware
| Judge | Period | PO Win Rate | 
|---|---|---|
| 09/07/22 - 05/07/24 | 42% | |
| 07/29/20 - 09/07/22 | 36% | 
Plaintiff
Attorney
| Name | Ratings | 
|---|---|
| L4 B | |
| L2 D | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| L4 D | |
| L5 A | |
| L3 A | |
| L1 D | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | 
No Attorneys
Defendant
Party
No Parties
Attorney
| Name | Ratings | 
|---|---|
| L5 B | |
| L5 E | |
| L5 E | |
| L2 E | |
| L1 D | |
| -- -- -- | |
| L4 B | |
| L4 E | |
| L3 A | |
| L2 E | |
| L1 B | |
| L1 C | |
| -- -- -- | |
| Shaw Keller LLPLocal | L4 D | 
| L5 B | |
| L5 E | |
| L5 E | |
| Morris James LLPLocal | L4 E | 
| L5 E | |
| Bayard PALocal | L4 E | 
| L5 E | |
| L2 D | |
| L4 E | |
| L5 E | |
| L5 E | |
| L3 C | |
| L4 B | |
| -- -- -- | |
| L2 E | |
| L1 C | |
| L1 E | |
| L3 E | |
| L2 E | |
| -- -- -- | |
| L1 E | |
| L5 E | |
| L4 E | |
| L4 E | |
| L4 E | 
No Attorneys